These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 29651186)

  • 21. Investigation of a combination therapy approach for the treatment of melioidosis.
    Barnes KB; Richards MI; Burgess G; Armstrong SJ; Bentley C; Maishman TC; Laws TR; Nelson M; Harding SV
    Front Microbiol; 2022; 13():934312. PubMed ID: 36051754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre- and post-exposure prophylaxis of experimental Burkholderia pseudomallei infection with doxycycline, amoxicillin/clavulanic acid and co-trimoxazole.
    Sivalingam SP; Sim SH; Jasper LC; Wang D; Liu Y; Ooi EE
    J Antimicrob Chemother; 2008 Mar; 61(3):674-8. PubMed ID: 18192684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment.
    Dance DA; Wuthiekanun V; Chaowagul W; White NJ
    J Antimicrob Chemother; 1989 Sep; 24(3):295-309. PubMed ID: 2681116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against
    Everaert A; Coenye T
    Antimicrob Resist Infect Control; 2016; 5():44. PubMed ID: 27895902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
    Turk Dagi H; Kus H; Arslan U; Tuncer I
    Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains.
    Miranda-Novales G; Leaños-Miranda BE; Vilchis-Pérez M; Solórzano-Santos F
    Ann Clin Microbiol Antimicrob; 2006 Oct; 5():25. PubMed ID: 17034644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro susceptibilities of Burkholderia mallei in comparison to those of other pathogenic Burkholderia spp.
    Kenny DJ; Russell P; Rogers D; Eley SM; Titball RW
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2773-5. PubMed ID: 10543761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents.
    Thibault FM; Hernandez E; Vidal DR; Girardet M; Cavallo JD
    J Antimicrob Chemother; 2004 Dec; 54(6):1134-8. PubMed ID: 15509614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro synergistic effect of doxycycline & ofloxacin in combination with ethanolic leaf extract of Vangueria spinosa against four pathogenic bacteria.
    Chatterjee SK; Bhattacharjee I; Chandra G
    Indian J Med Res; 2009 Oct; 130(4):475-8. PubMed ID: 19942754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination antimicrobial therapy of acute Burkholderia pseudomallei infection in a mouse model.
    Ulett GC; Norton RE; Hirst RG
    Pathology; 1999 Aug; 31(3):264-7. PubMed ID: 10503275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of bla(PenA) and bla(OXA) in Burkholderia pseudomallei Isolated from Patients at Sappasitthiprasong Hospital and Their Susceptibility to Ceftazidime and Carbapenems.
    Panya M; Thirat S; Wanram S; Panomket P; Nilsakul J
    J Med Assoc Thai; 2016 Jan; 99 Suppl 1():S12-6. PubMed ID: 26817233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Open-label randomized trial of oral trimethoprim-sulfamethoxazole, doxycycline, and chloramphenicol compared with trimethoprim-sulfamethoxazole and doxycycline for maintenance therapy of melioidosis.
    Chaowagul W; Chierakul W; Simpson AJ; Short JM; Stepniewska K; Maharjan B; Rajchanuvong A; Busarawong D; Limmathurotsakul D; Cheng AC; Wuthiekanun V; Newton PN; White NJ; Day NP; Peacock SJ
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4020-5. PubMed ID: 16189075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Investigations of PenA-mediated β-lactam Resistance in Burkholderia pseudomallei.
    Rholl DA; Papp-Wallace KM; Tomaras AP; Vasil ML; Bonomo RA; Schweizer HP
    Front Microbiol; 2011; 2():139. PubMed ID: 21747814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and anti Methicillin resistant Staphylococcus aureus activity of substituted chalcones alone and in combination with non-beta-lactam antibiotics.
    Tran TD; Do TH; Tran NC; Ngo TD; Huynh TN; Tran CD; Thai KM
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4555-60. PubMed ID: 22727643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Burkholderia pseudomallei resistance to antibiotics in biofilm-induced conditions is related to efflux pumps.
    Sirijant N; Sermswan RW; Wongratanacheewin S
    J Med Microbiol; 2016 Nov; 65(11):1296-1306. PubMed ID: 27702426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combinations of vancomycin and beta-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin.
    Climo MW; Patron RL; Archer GL
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1747-53. PubMed ID: 10390234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro efficacy of several antimicrobial combinations against Brucella canis and Brucella melitensis strains isolated from dogs.
    Mateu-de-Antonio EM; Martín M
    Vet Microbiol; 1995 Jun; 45(1):1-10. PubMed ID: 7653024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cefotaxime and Amoxicillin-Clavulanate Synergism against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Urinary Tract Infection.
    Rossi B; Soubirou JF; Chau F; Massias L; Dion S; Lepeule R; Fantin B; Lefort A
    Antimicrob Agents Chemother; 2016 Jan; 60(1):424-30. PubMed ID: 26525800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Susceptibility of Pseudomonas pseudomallei to some newer beta-lactam antibiotics and antibiotic combinations using time-kill studies.
    Smith MD; Wuthiekanun V; Walsh AL; White NJ
    J Antimicrob Chemother; 1994 Jan; 33(1):145-9. PubMed ID: 7512547
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.